Strategies to Improve the Effect of Vaccination in the Elderly: the Vaccine Producer's Perspective

Journal of Comparative Pathology

Volumn 142, Issue SUPPL. 1, 2010, Pages

  Guy, B ^a  

^a SANOFI PASTEUR   (France)

Author keywords

adjuvant; elderly people; vaccination

Indexed keywords

CHICKENPOX VACCINE; CONJUGATE VACCINE; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; EPITOPE; INTERLEUKIN 7; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; AGED; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CYTOMEGALOVIRUS; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG MEGADOSE; ELDERLY CARE; HELPER CELL; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; IMMUNOSENESCENCE; MEMORY CELL; PRIORITY JOURNAL; REVIEW; STRATEGIC PLANNING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIGEN-PRESENTING CELLS; HUMANS; VACCINATION; VACCINES;

CYTOMEGALOVIRUS;

EID: 73249131742     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.09.009     Document Type: Review

References (31)

1. Alignani D., Maletto B., Liscovsky M., Rópolo A., Morón G., et al. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. Journal of Leukocyte Biology 77 (2005) 898-905
2. Aspinall R., Pido-Lopez J., Imami N., Henson S.M., Ngom P.T., et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Research 10 (2007) 5-17
3. Boudet F. Vaccines for the elderly: the quest for the ideal animal model. Journal of Comparative Pathology 142 (2010) S70-S73
4. Couch R.B., Winokur P., Brady R., Belshe R., Chen W.H., et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 25 (2007) 7656-7663
5. Dorshkind K., Montecino-Rodriguez E., and Signer R.A. The ageing immune system: is it ever too old to become young again?. Nature Reviews Immunology 9 (2009) 57-62
6. Gasparini R., Pozzi T., Montomoli E., Fragapane E., Senatore F., et al. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. European Journal of Epidemiology 17 (2001) 135-140
7. Guy B. The perfect mix: recent progress in adjuvant research. Nature Reviews Microbiology 5 (2007) 505-517
8. Haynes L., Eaton S.M., Burns E.M., Randall T.D., and Swain S.L. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proceedings of the National Academy of Sciences USA 100 (2003) 15053-15058
9. Haynes L., Eaton S.M., Burns E.M., Rincon M., and Swain S.L. Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo. Journal of Immunology 172 (2004) 5194-5199
10. Haynes L., and Swain S.L. Why aging T cells fail: implications for vaccination. Immunity 24 (2006) 663-666
11. Holland D., Booy R., De Looze F., Eizenberg P., McDonald J., et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. Journal of Infectious Diseases 198 (2008) 650-658
12. Iob A., Brianti G., Zamparo E., and Gallo T. Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy. Epidemiology and Infection 133 (2005) 687-693
13. Kaml M., Weiskirchner I., Keller M., Luft T., Hoster E., et al. Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers. Vaccine 24 (2006) 6808-6811
14. Kovaiou R.D., Herndler-Brandstetter D., and Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Reviews in Molecular Medicine 9 (2007) 1-17
15. Kumar R., and Burns E.A. Age-related decline in immunity: implications for vaccine responsiveness. Expert Reviews in Vaccines 7 (2008) 467-479
16. Lung T.L., Saurwein-Teissl M., Parson W., Schönitzer D., and Grubeck-Loebenstein B. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18 (2000) 1606-1612
17. Maletto B.A., Rópolo A.S., Liscovsky M.V., Alignani D.O., Glocker M., et al. CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. Clinical Immunology 117 (2005) 251-261
18. Maue A.C., Eaton S.M., Lanthier P.A., Sweet K.B., Blumerman S.L., et al. Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells. Journal of Immunology 182 (2009) 6129-6135
19. Nicolas J.F., and Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Reviews in Vaccines 7 (2008) 1201-1214
20. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., and Wikby A. Cytomegalovirus and human immunosenescence. Reviews in Medical Virology 19 (2009) 47-56
21. Posnett D.N., Engelhorn M.E., Lin Y., Merghoub T., Duan F., et al. Development of effective vaccines for old mice in a tumor model. Vaccine 27 (2009) 1093-1100
22. Ridda I., Macintyre C.R., Lindley R., Gao Z., Sullivan J.S., et al. Immunological responses to pneumococcal vaccine in frail older people. Vaccine 27 (2009) 1628-1636
23. + T-regulatory cells. Journal of Immunotherapy 29 (2006) 313-319
24. Schenkein J.G., Park S., and Nahm M.H. Pneumococcal vaccination in older adults induces antibodies with low opsonic capacity and reduced antibody potency. Vaccine 26 (2008) 5521-5526
25. Siegrist C.A., and Aspinall R. B-cell responses to vaccination at the extremes of age. Nature Reviews Immunology 9 (2009) 185-194
26. Simell B., Lahdenkari M., Reunanen A., Käyhty H., and Väkeväinen M. Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins. Clinical and Vaccine Immunology 15 (2008) 1391-1397
27. Sportès C., Hakim F.T., Memon S.A., Zhang H., Chua K.S., et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. Journal of Experimental Medicine 205 (2008) 1701-1714
28. Sutradhar S.C., Wang W.W., Schlienger K., Stek J.E., Xu J., et al. Comparison of the levels of immunogenicity and safety of Zostavax in adults 50-59 years old and in adults 60 years old or older. Clinical and Vaccine Immunology 16 (2009) 646-652
29. Trzonkowski P., Mysliwska J., Pawelec G., and Mysliwski A. From bench to bedside and back: the SENIEUR protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 10 (2009) 83-94
30. Trzonkowski P., Mysliwska J., Szmit E., Wieckiewicz J., Lukaszuk K., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 21 (2003) 3826-3836
31. Woodland D.L., and Blackman M.A. Immunity and age: living in the past?. Trends in Immunology 27 (2006) 303-307